RAPS

Do Drugs Approved Via Expedited Pathways Offer Greater Benefits? Study and Doctors Debate

A recent study in Health Affairs suggests that drugs given an expedited review by the US Food and Drug Administration (FDA) offer greater health gains than drugs that receiving a conventional review.
RAPS

Study: Are FDA's Expedited Approval Pathways Worth the Risk?

The US Food and Drug Administration (FDA) has long been at the center of a passionate debate between industry and patient safety advocates: Is the agency too slow at approving new products, leaving ...
American Hospital Association

CMS, FDA announce pathway to expedite access to certain medical devices for Medicare beneficiaries

The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to ...
Detroit Free Press

In Support of Possible Expedited Approval Pathway for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID), Jaguar Health Submits Amended Protocol to FDA for ...

SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 20, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that, in support of a possible ...